TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 8935224

Group type: EXPERIMENTAL
Intervention: 20 mg omeprazole q.d. for 28 days plus 750 mg amoxicillin b.i.d. for the first 10 days (omep-20-amox group, N = 22)
Number of subjects: 112

Group type: EXPERIMENTAL
Intervention: 20 mg omeprazole b.i.d. for 28 days plus 750 mg amoxicillin b.i.d. for the first 10 days (omep-40-amox group, N = 22)
Number of subjects: 112

Group type: EXPERIMENTAL
Intervention: 300 mg bismuth subsalicylate q.i.d. for 28 days, and 750 mg amoxicillin b.i.d., 500mg metronidazole t.i.d. for the first 7 days (triple therapy group, N = 25)
Number of subjects: 112

Group type: EXPERIMENTAL
Intervention: 20 mg omeprazole q.d. for 28 days (omep-20 group, N = 22)
Number of subjects: 112

Group type: EXPERIMENTAL
Intervention: 150 mg ranitidine b.i.d. or 400 mg cimetidine b.i.d. for 28 days (H2-antagonist group, N = 21)
Number of subjects: 112

Group type: EXPERIMENTAL
Intervention: Triple therapy group (N = 25)
Number of subjects: 112

Group type: EXPERIMENTAL
Intervention: Omep-20-amox, omep-40-amox, triple therapy, omep-20 groups
Number of subjects: 112

Group type: EXPERIMENTAL
Intervention: H2 antagonist group
Number of subjects: 112
Study: 1526418

Group type: EXPERIMENTAL
Intervention: 5-aminosalicylic acid enema (1 g daily for 2 weeks)
Number of subjects: 199

Group type: COMPARATOR
Intervention: Hydrocortisone acetate foam (90 mg daily for 2 weeks)
Number of subjects: 199
Study: 3885626

Group type: EXPERIMENTAL
Intervention: Postoperative irradiation (50 Gy)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Preoperative irradiation + postoperative saturation (25 Gy)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Preoperative irradiation alone (25 Gy)
Number of subjects: 0
Study: 29486867

Group type: EXPERIMENTAL
Intervention: Internet-based cognitive behavioral therapy (iCBT)
Number of subjects: 73

Group type: COMPARATOR
Intervention: Monitored attention control
Number of subjects: 73
Study: 28724423

Group type: EXPERIMENTAL
Intervention: Telephone-administered short-term cognitive-behavioural therapy (T-CBT)
Number of subjects: 216

Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 216
Study: 26151135

Group type: EXPERIMENTAL
Intervention: Yokukansan (YKS) 2.5 g/day
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Yokukansan (YKS) 5.0 g/day
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Yokukansan (YKS) 7.5 g/day
Number of subjects: 21
Study: 24140940

Group type: EXPERIMENTAL
Intervention: Open technique with extensive manipulation (GROUP A)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Open technique with minimal manipulation (GROUP B)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Laparoscopic technique (GROUP C)
Number of subjects: 90
Study: 21059701

Group type: EXPERIMENTAL
Intervention: Ultrasound (US)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Nerve stimulation (NS)
Number of subjects: 0
Study: 18356657

Group type: EXPERIMENTAL
Intervention: mini-cardiopulmonary bypass (CPB)
Number of subjects: 98
Study: 16440364

Group type: EXPERIMENTAL
Intervention: Lamivudine treatment
Number of subjects: 276

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 276

Group type: EXPERIMENTAL
Intervention: YMDD mutant HBV
Number of subjects: 276

Group type: EXPERIMENTAL
Intervention: Non-YMDD mutant HBV
Number of subjects: 276

Group type: COMPARATOR
Intervention: Observation arm
Number of subjects: 276
Study: 12580664

Group type: EXPERIMENTAL
Intervention: Boxing trials at various tempos (60, 72, 84, 96, 108, and 120 b.min(‐1))
Number of subjects: 18
Study: 11100345

Group type: EXPERIMENTAL
Intervention: Injection of absolute alcohol (n = 44)
Number of subjects: 208

Group type: EXPERIMENTAL
Intervention: Multipolar electrocoagulation (BICAP; n = 42)
Number of subjects: 208

Group type: EXPERIMENTAL
Intervention: Nd‐YAG laser (n = 40)
Number of subjects: 208

Group type: EXPERIMENTAL
Intervention: Injection of absolute ethanol + octreotide (n = 42)
Number of subjects: 208

Group type: EXPERIMENTAL
Intervention: Injection of absolute ethanol + omeprazole (n = 40)
Number of subjects: 208
Study: 9345156

Group type: EXPERIMENTAL
Intervention: Nonextraction orthodontic treatment
Number of subjects: 35

Group type: COMPARATOR
Intervention: Extraction orthodontic treatment
Number of subjects: 35
Study: 8462205

Group type: EXPERIMENTAL
Intervention: Dermatan sulfate (DS) 6 mg/kg body weight
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard heparin treatment
Number of subjects: 0
Study: 3756057

Group type: EXPERIMENTAL
Intervention: Metoprolol (M) 0.2 mg kg‐1 i.v. and dihydralazine (DH) 0.2 mg kg‐1 i.v.
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Dihydralazine (DH) 0.2 mg kg‐1 i.v. alone
Number of subjects: 51

Group type: COMPARATOR
Intervention: Saline (control)
Number of subjects: 51
Study: 29776872

Group type: EXPERIMENTAL
Intervention: Lullaby
Number of subjects: 106

Group type: EXPERIMENTAL
Intervention: Oral Glucose
Number of subjects: 106

Group type: COMPARATOR
Intervention: Control
Number of subjects: 106
Study: 28487001

Group type: EXPERIMENTAL
Intervention: CMS nonpayment policy implementation
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (non-Medicare patients)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Comparison of Medicare population to control group
Number of subjects: 0
Study: 25987694

Group type: EXPERIMENTAL
Intervention: Enoxaparin (low-molecular weight heparin)
Number of subjects: 312

Group type: COMPARATOR
Intervention: Chemotherapy alone (observation group)
Number of subjects: 312
Study: 23339958

Group type: EXPERIMENTAL
Intervention: Warfarin
Number of subjects: 1028

Group type: COMPARATOR
Intervention: Aspirin
Number of subjects: 1028

Group type: EXPERIMENTAL
Intervention: Warfarin vs Aspirin
Number of subjects: 1028
Study: 20717848

Group type: EXPERIMENTAL
Intervention: Therapeutic nasal CPAP
Number of subjects: 17

Group type: COMPARATOR
Intervention: Sham nasal CPAP
Number of subjects: 17
Study: 19021919

Group type: EXPERIMENTAL
Intervention: Healthy reduced-salt Japanese diet (dietary score 3)
Number of subjects: 9086

Group type: EXPERIMENTAL
Intervention: Healthy reduced-salt Japanese diet (dietary score 4-7)
Number of subjects: 9086

Group type: COMPARATOR
Intervention: Dietary score group 0-2 (reference group)
Number of subjects: 9086
Study: 17512256

Group type: EXPERIMENTAL
Intervention: Intravenous amitriptyline 25 mg
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Intravenous amitriptyline 50 mg
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Intravenous amitriptyline 100 mg
Number of subjects: 10
Study: 15152535

Group type: EXPERIMENTAL
Intervention: Rectal naproxen
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 11216935

Group type: EXPERIMENTAL
Intervention: CMV seroconversion
Number of subjects: 290
Study: 9772850

Group type: EXPERIMENTAL
Intervention: Behavioral intervention targeting aggressive/disruptive behavior
Number of subjects: 2311

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 2311
Study: 8170427

Group type: EXPERIMENTAL
Intervention: Educational mailing campaign and pharmacist visit
Number of subjects: 182

Group type: COMPARATOR
Intervention: Standard practice (Control)
Number of subjects: 182
Study: 2453226

Group type: EXPERIMENTAL
Intervention: Intravenous administration
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Peroral administration
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Rectal administration
Number of subjects: 0
Study: 31124396

Group type: EXPERIMENTAL
Intervention: Two-stage least squares estimation using cluster-level summaries
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Adjustment for baseline covariates
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Appropriate degrees of freedom correction for inference
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Simulations of two-stage least squares
Number of subjects: 0
Study: 30019241

Group type: EXPERIMENTAL
Intervention: Botulinum toxin type A (BTA) injected in the early postoperative period
Number of subjects: 19

Group type: COMPARATOR
Intervention: Normal saline (control)
Number of subjects: 19
Study: 28045276

Group type: EXPERIMENTAL
Intervention: Rating facial feature similarity prior to making same/different identity decisions to pairs of face images
Number of subjects: 0

Group type: COMPARATOR
Intervention: Rating similarity of personality traits and image quality parameters
Number of subjects: 0

Group type: COMPARATOR
Intervention: Comparison of trained forensic facial image examiners
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Aggregating feature ratings of multiple examiners
Number of subjects: 0
Study: 26169675

Group type: EXPERIMENTAL
Intervention: Web-based education program
Number of subjects: 21

Group type: COMPARATOR
Intervention: Waiting list control group
Number of subjects: 21
Study: 23985411

Group type: EXPERIMENTAL
Intervention: Sildenafil (started 2 weeks before surgery and continued postoperatively at 0.5 mg/kg, increased to a maximum of 2 mg/kg)
Number of subjects: 101

Group type: COMPARATOR
Intervention: Control group (sildenafil started only postoperatively at 0.5 mg/kg, increased to a maximum of 2 mg/kg)
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: Sildenafil group
Number of subjects: 101

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 101
Study: 21218289

Group type: EXPERIMENTAL
Intervention: Sleep deprivation
Number of subjects: 23

Group type: COMPARATOR
Intervention: Normal sleep control
Number of subjects: 23
Study: 18439313

Group type: EXPERIMENTAL
Intervention: Whole‐kernel wheat bread with vinegar
Number of subjects: 15

Group type: COMPARATOR
Intervention: Wholemeal wheat bread
Number of subjects: 15

Group type: COMPARATOR
Intervention: White wheat bread with vinegar
Number of subjects: 15

Group type: COMPARATOR
Intervention: Reference meal (white wheat bread without vinegar)
Number of subjects: 15
Study: 16503536

Group type: EXPERIMENTAL
Intervention: Trimetazidine 20 mg 3 times daily for 8 weeks
Number of subjects: 119

Group type: COMPARATOR
Intervention: Basic therapy (Control group A)
Number of subjects: 119
Study: 14550702

Group type: EXPERIMENTAL
Intervention: Vibrating gel-based insoles
Number of subjects: 27
Study: 10902887

Group type: EXPERIMENTAL
Intervention: Polyurethane foam cushions (50, 70, 100, 120 mm thick)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Cushions with lower stiffness
Number of subjects: 32

Group type: COMPARATOR
Intervention: Rigid wooden seat
Number of subjects: 32
Study: 8936659

Group type: EXPERIMENTAL
Intervention: Somatostatin (octreotide 200 micrograms q8h subcutaneously)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Corticosteroid (prednisone 1 mg/kg/day in decreasing doses)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Both groups (Somatostatin and Corticosteroid)
Number of subjects: 18
Study: 1543852

Group type: EXPERIMENTAL
Intervention: Oxygenator exhaust capnography
Number of subjects: 40
Study: 6388810

Group type: EXPERIMENTAL
Intervention: Conservation surgery and irradiation
Number of subjects: 1073

Group type: COMPARATOR
Intervention: Radical or modified radical mastectomy
Number of subjects: 1073

Group type: EXPERIMENTAL
Intervention: Radiation therapy for first breast cancer
Number of subjects: 1073
Study: 31094074

Group type: EXPERIMENTAL
Intervention: Lixisenatide 20 μg
Number of subjects: 108

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 108
Study: 29548848

Group type: EXPERIMENTAL
Intervention: Resveratrol (200 mg/day) for 26 weeks
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo for 26 weeks
Number of subjects: 60
Study: 27144849

Group type: EXPERIMENTAL
Intervention: Rosuvastatin (20 mg daily)
Number of subjects: 1922

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1922
Study: 25209956

Group type: EXPERIMENTAL
Intervention: Proximal exercise outcome condition (experienced during or directly following an exercise bout)
Number of subjects: 135

Group type: COMPARATOR
Intervention: Distal exercise outcome condition (experienced after days, months, or years of regular exercise)
Number of subjects: 135
Study: 20629075

Group type: EXPERIMENTAL
Intervention: Rotigotine 2 mg/24 hr
Number of subjects: 505

Group type: EXPERIMENTAL
Intervention: Rotigotine 3 mg/24 hr
Number of subjects: 505

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 505
Study: 15546135

Group type: EXPERIMENTAL
Intervention: High dose melphalan (180 mg/m²) with autologous bone marrow support
Number of subjects: 167

Group type: COMPARATOR
Intervention: No further treatment (control group)
Number of subjects: 167
Study: 11674981

Group type: EXPERIMENTAL
Intervention: 4 motor responses located (Group A)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: 3 motor responses located (Group B)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: 2 motor responses located (Group C)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: 2 non-musculocutaneous responses located (Group D)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: 1 non-musculocutaneous response located (Group E)
Number of subjects: 100
Study: 10420071

Group type: EXPERIMENTAL
Intervention: Low molecular weight heparin (LMWH) 1 mg/kg body weight
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Combined LMWH-adjusted dose plus UFH 2,500 IU fix dose (ComHep)
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: UFH 2,500 IU/10 kg body weight (UFHvar)
Number of subjects: 5

Group type: COMPARATOR
Intervention: UFH 2,500 IU fix dose (FixUFH)
Number of subjects: 5
Study: 8048850

Group type: EXPERIMENTAL
Intervention: Three-quarter Nissen fundoplication with dissection and exclusion of vagus nerves
Number of subjects: 42

Group type: COMPARATOR
Intervention: Three-quarter Nissen fundoplication without dissection and exclusion of vagus nerves
Number of subjects: 42
Study: 2903085

Group type: EXPERIMENTAL
Intervention: Cyclophosphamide + cisplatin (CP)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Cyclophosphamide + doxorubicin + cisplatin (CAP)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Cyclophosphamide + 4'-epi-doxorubicin + cisplatin (CEP)
Number of subjects: 48
Study: 12843342

Group type: EXPERIMENTAL
Intervention: Intra-arterial thrombolysis with recombinant pro-urokinase
Number of subjects: 154

Group type: COMPARATOR
Intervention: Control
Number of subjects: 154
Study: 30221596

Group type: EXPERIMENTAL
Intervention: Aspirin (100 mg per day)
Number of subjects: 19114

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 19114
Study: 27585746

Group type: EXPERIMENTAL
Intervention: NDT-Bobath method
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: PNF method
Number of subjects: 72
Study: 23920050

Group type: EXPERIMENTAL
Intervention: Clinical groups (FEP, ARMS, HSC)
Number of subjects: 191

Group type: COMPARATOR
Intervention: Non-help-seeking group (NH)
Number of subjects: 191

Group type: EXPERIMENTAL
Intervention: Negative beliefs about self and others
Number of subjects: 191
Study: 22442350

Group type: EXPERIMENTAL
Intervention: Patients with a donor (allo-SCT)
Number of subjects: 260

Group type: COMPARATOR
Intervention: Patients without a donor (no-allo-SCT)
Number of subjects: 260

Group type: EXPERIMENTAL
Intervention: Both groups (donor and no-donor)
Number of subjects: 260

Group type: EXPERIMENTAL
Intervention: Patients who proceeded to allo-SCT
Number of subjects: 260

Group type: COMPARATOR
Intervention: Patients who continued maintenance or received a second high-dose melphalan
Number of subjects: 260
Study: 20410834

Group type: EXPERIMENTAL
Intervention: Pantoprazole
Number of subjects: 336

Group type: COMPARATOR
Intervention: No PPI
Number of subjects: 336

Group type: COMPARATOR
Intervention: Omeprazole/Esomeprazole
Number of subjects: 336
Study: 18840153

Group type: EXPERIMENTAL
Intervention: Adequate allocation concealment
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Adequate examiner masking
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Retrospective power calculation
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Clinical outcomes in periodontology trials
Number of subjects: 35
Study: 15960637

Group type: EXPERIMENTAL
Intervention: Leaflet received by post 1 week after presurgical assessment (n = 19)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Leaflet received at presurgical assessment clinic (n = 21)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Leaflet received within 2 weeks of surgery (method not specified)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Both groups (post and clinic delivery)
Number of subjects: 40
Study: 12800397

Group type: EXPERIMENTAL
Intervention: Thrombolysis (streptokinase) in community hospitals (Group A)
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Thrombolytic infusion during transport to PCI center for coronary angioplasty (Group B)
Number of subjects: 66

Group type: COMPARATOR
Intervention: Primary angioplasty without thrombolysis (Group C)
Number of subjects: 66
Study: 10593459

Group type: EXPERIMENTAL
Intervention: Rewarming to bladder temperature of 37-38.5 degrees C (group W)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Rewarming to bladder temperature of 35-37 degrees C (group C)
Number of subjects: 38
Study: 8731761

Group type: COMPARATOR
Intervention: Diethylcarbamazine (DEC) 6 mg/kg
Number of subjects: 57

Group type: COMPARATOR
Intervention: Ivermectin (IVR) 400 micrograms/kg
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Combination of Ivermectin (IVR) 400 micrograms/kg and Diethylcarbamazine (DEC) 6 mg/kg
Number of subjects: 57
Study: 2013676

Group type: EXPERIMENTAL
Intervention: Aspartame (up to 2000 mg)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo (not explicitly mentioned but implied as part of the double-blind design)
Number of subjects: 12
Study: 7048338

Group type: EXPERIMENTAL
Intervention: 100 mg labetalol 3-times daily
Number of subjects: 10

Group type: COMPARATOR
Intervention: 250 mg alpha‐methyldopa 3-times daily
Number of subjects: 10
Study: 31618177

Group type: EXPERIMENTAL
Intervention: ESOB containing phlai oil
Number of subjects: 38

Group type: COMPARATOR
Intervention: Olive oil (control)
Number of subjects: 38
Study: 29669426

Group type: EXPERIMENTAL
Intervention: Cooperative membership
Number of subjects: 256

Group type: COMPARATOR
Intervention: Non-membership (Control)
Number of subjects: 256
Study: 26831332

Group type: EXPERIMENTAL
Intervention: Nurse-driven targeted HIV screening combined with current practice (physician-directed diagnostic testing)
Number of subjects: 140000

Group type: COMPARATOR
Intervention: Current practice alone (physician-directed diagnostic testing)
Number of subjects: 140000
Study: 24531816

Group type: EXPERIMENTAL
Intervention: One-shot dilator (group A)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Telescopic metal dilator (group B)
Number of subjects: 100
Study: 22668621

Group type: EXPERIMENTAL
Intervention: Transcutaneous electrical nerve stimulation (TENS) sialogogue
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Combined mechanical/electrical sialogogue
Number of subjects: 35

Group type: COMPARATOR
Intervention: Mechanical sialogogue
Number of subjects: 35

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 35
Study: 20155644

Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study: 17414235

Group type: EXPERIMENTAL
Intervention: Low-concentration desipramine (<60 ng/mL)
Number of subjects: 121

Group type: COMPARATOR
Intervention: Active placebo (benztropine mesylate)
Number of subjects: 121

Group type: EXPERIMENTAL
Intervention: Higher concentrations of desipramine (>60 ng/mL)
Number of subjects: 121

Group type: EXPERIMENTAL
Intervention: All concentrations of fluoxetine
Number of subjects: 121
Study: 15808325

Group type: EXPERIMENTAL
Intervention: High dose fish oil (14 g/day)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: 10 microM of HHE
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Mixtures of HHE and HNE
Number of subjects: 30
Study: 11953635

Group type: EXPERIMENTAL
Intervention: Digital radiographs
Number of subjects: 20

Group type: COMPARATOR
Intervention: Plain radiographs
Number of subjects: 20
Study: 9475852

Group type: EXPERIMENTAL
Intervention: Inflation of trouser legs
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Inflation of trouser legs and abdominopelvic region
Number of subjects: 16

Group type: COMPARATOR
Intervention: No trouser inflation (control)
Number of subjects: 16
Study: 8593095

Group type: EXPERIMENTAL
Intervention: Sulacillin (a combination of sodium ampicillin and sulbactam in a 2:1 ratio)
Number of subjects: 0
Study: 2923085

Group type: EXPERIMENTAL
Intervention: Milk (900 mg Ca daily)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Calcium chloride (CaCl, 900 mg Ca daily)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Calcium carbonate (CaCO3, 900 mg Ca daily)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Calcium supplements (milk, CaCl, CaCO3)
Number of subjects: 8
Study: 337536

Group type: EXPERIMENTAL
Intervention: Japanese applicator (27 punctures)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Heaf multipuncture apparatus (40 punctures)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Intradermal method of vaccination
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Japanese BCG vaccine (percutaneous)
Number of subjects: 0
Study: 30170952

Group type: EXPERIMENTAL
Intervention: NaHCO3− (0.3 g.kg−1 body weight)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: NaHCO3−
Number of subjects: 12
Study: 28615070

Group type: EXPERIMENTAL
Intervention: Tildipirosin 4 mg/kg, subcutaneously (n = 109)
Number of subjects: 209

Group type: COMPARATOR
Intervention: Placebo 0.9% saline, subcutaneously (n = 100)
Number of subjects: 209
Study: 25959989

Group type: EXPERIMENTAL
Intervention: Pre-ART inflammatory markers (CRP, IL-6, D-dimer)
Number of subjects: 1084
Study: 23470859

Group type: EXPERIMENTAL
Intervention: Clinical interpretation of stenosis severity
Number of subjects: 175

Group type: COMPARATOR
Intervention: Quantitative coronary angiography (QCA)
Number of subjects: 175

Group type: EXPERIMENTAL
Intervention: Clinical interpretation
Number of subjects: 175

Group type: COMPARATOR
Intervention: QCA
Number of subjects: 175
Study: 21787399

Group type: EXPERIMENTAL
Intervention: Clothes peg pain provocation test
Number of subjects: 157

Group type: COMPARATOR
Intervention: Electronic pressure algometer
Number of subjects: 157
Study: 19567540

Group type: EXPERIMENTAL
Intervention: Caloric restriction (CR) + Resistance training (RT)
Number of subjects: 107

Group type: COMPARATOR
Intervention: Caloric restriction (CR)
Number of subjects: 107
Study: 16514132

Group type: EXPERIMENTAL
Intervention: Ideal 1 self-etching primer
Number of subjects: 20

Group type: COMPARATOR
Intervention: Conventional acid etching (37% o-phosphoric acid)
Number of subjects: 20
Study: 15235317

Group type: EXPERIMENTAL
Intervention: 60-min bout of cycling exercise at approximately 65% of peak oxygen uptake
Number of subjects: 11

Group type: COMPARATOR
Intervention: Nonexercise condition
Number of subjects: 11